Company news
HCW Biologics Inc. news in 2024
HCW Biologics Inc.'s news releases, calls and decks from 2024, newest first.
HCW Biologics Inc. Received NASDAQ Staff Determination Letter
December 22, 2024
HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules
November 17, 2024
HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate
November 17, 2024
HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights
November 13, 2024
HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction
August 22, 2024
HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights
August 13, 2024
HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights
May 14, 2024
HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights
March 31, 2024